US headquartered Foxx Life Sciences plans to invest Rs. 200 cr in Telangana

HYDERABAD: US headquartered Foxx Life Sciences plans to invest Rs. 200 crores in Telangana to expand capabilities in Pharmaceutical Single Use Technology for Drug Manufacturing(SUT).

The company had chosen Telangana as their first international plant few years ago and successfully started warehouse, White Room for Laboratory products and State of the Art Class VI clean Room.

Foxx Life Sciences is a privately held world leader in custom single-use systems (SUS) including tubing, bag, bottle, flask and carboy assemblies, filtration, fluid management, laboratory safety products, plastic labware, tubing, gaskets, hoses, stainless steel and glassware for the research, biotech, and pharmaceutical industries.

Eknath Kulkarni, Managing Director, Foxx Life Sciences India said that “Foxx Life Sciences is proud to choose Hyderabad, for our first international plant. I thank Mr. Thomas Taylor, our President for selecting Hyderabad location to grow Foxx. Our President admires vibrant pharma ecosystem of Hyderabad and acknowledges the rapid growth potential in coming years. Also, we value the support and encouragement receives from the state and committed to develop world class facility to support customers with custom medical and SUT Pharma assemblies at a lower cost.”

Surface Measurement Systems group of companies which provides world leading technology and science on particulate material announced opening up of their Particle Characterization Laboratories (PCL) with total investment of over USD 2 million dollars initial capital investment and planning to invest USD 3 million over the next 3 years of operations.

Minister KT Rama Rao had met with the Managing Director of the company Professor Daryl Williams during his visit to UK in May 2022 and the company has already completed establishment of their facility at international standards.

Minister KT Rama Rao said that “I congratulate Professor Daryl Williams and his team for opening up of Particle Characterisation Laboratories in Hyderabad. This is a remarkable accomplishment and I wish them all the very best in this new endeavor.”

Particle Characterisation Laboratories (PCL) is an exciting new contract research organisation (CRO) opening in Hyderabad, India, to serve the global research community. This unique laboratory will provide easy access to a broad range of particle characterisation services employing highly specialised experts. PCL will become a world-renowned hub for the advanced scientific characterisation of powders, solid state materials and particulates.

Eagle Genomics, a pioneering tech bio platform company headquartered in UK, has announced that it is expanding its capabilities rapidly in Hyderabad. The company leadership met with Hon Minister KT Rama Rao during the BioAsia 2023 event and informed him of their aggressive expansion plans. The company which started with 20 employees a few years ago has already grown to 61 engaged in cutting edge bioinformatics and data analytics works.

The major centre for the technology and biotechnology industries (India’s Genome Valley), has been an important milestone in Eagle Genomics’ customer-driven expansion. Eagle Genomics sees India as a critical base as part of its continued international expansion. Eagle Genomics a pioneering TechBio platform business innovating at the intersection of biology, data sciences and bioinformatics, to accelerate the Bioeconomy through the digital reinvention of life sciences R&D.

The company's award-winning AI-augmented knowledge discovery platform, e[datascientist]™️, empowers scientists to exploit multi-dimensional data in minutes rather than months, to help companies conduct science-led innovation for next-generation products, at scale. By harnessing nature - including its complex networks and associated multi-dimensional data – Eagle Genomics is helping to tackle the world’s “Grand Challenges” while unlocking significant economic potential.